You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunomonitoring

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

Completed
  • Multiple Myeloma
  • Blood and bone marrow sampling
  • Rennes, France
    CHU Rennes
Feb 2, 2023

Breast Cancer Trial in Besançon, Dijon (blood sample)

Recruiting
  • Breast Cancer
  • blood sample
  • Besançon, France
  • +1 more
Mar 29, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Systemic Lupus Erythematosus (SLE) Trial in Marseille (polymerase chain reaction (PCR) technique of blood transcriptome

Terminated
  • Systemic Lupus Erythematosus (SLE)
  • polymerase chain reaction (PCR) technique of blood transcriptome analysis
  • Marseille, France
    Hôpital de la conception Assistance Publique Hôpitaux de Marseil
Aug 12, 2021

Metastatic Melanoma Trial in Pierre-Bénite (Blood and biopsy sampling)

Completed
  • Metastatic Melanoma
  • Blood and biopsy sampling
  • Pierre-Bénite, France
    Service de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
Dec 23, 2021

Research in Patients With Squamous Cell Anal Carcinoma

Withdrawn
  • Anal Canal Cancer
  • Additional biological samples
  • Besançon, France
  • +1 more
Jul 26, 2021

SARS-CoV-2 Coronavirus, Acute Respiratory Distress Syndrome Trial in Rennes (Blood samples collection, Saliva collection)

Recruiting
  • SARS-CoV-2 Coronavirus
  • Acute Respiratory Distress Syndrome
  • Blood samples collection
  • Saliva collection
  • Rennes, France
    CHU Rennes
Jun 28, 2021

Immunomonitoring of Interventional Radiology Procedures in

Not yet recruiting
  • Hepatocellular Carcinoma
  • Percutaneous ablation
  • (no location specified)
May 14, 2021

Oral Cavity Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab)

Active, not recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Amsterdam, Noord-Holland, Netherlands
    VU University medical center
Oct 6, 2021

Immunomonitoring After Hematopoietic Stem Cell Transplantation

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
    • (no location specified)
    Nov 12, 2020

    NSCLC Metastatic Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Dendritic cell immunotherapy
    • +2 more
    • Ghent, Belgium
      Ghent University Hospital
    Mar 29, 2021

    Kidney Transplant Infection Trial in Bordeaux, Lyon (Group 1_No proph treatment, Group 2A_Proph treatment and ?d T cell

    Completed
    • Kidney Transplant Infection
    • Group 1_No proph treatment
    • +2 more
    • Bordeaux, France
    • +1 more
    Jun 4, 2021

    Immune Profile of Young Patients After Treatment for Breast

    Recruiting
    • Breast Cancer
    • Immunomonitoring
    • Grenoble, France
      Chu Grenoble Alpes
    Dec 3, 2020

    Crohn Disease Trial in Montpellier (Immunomonitoring-based follow-up, Standard follow-up)

    Recruiting
    • Crohn Disease
    • Immunomonitoring-based follow-up
    • Standard follow-up
    • Montpellier, France
      CHU de Montpellier
    Apr 29, 2020

    Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
    • Immuno monitoring
    • Montpellier, France
      University hospital
    Dec 13, 2022

    Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

    Terminated
    • Multiple Myeloma
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Giant Cell Arteritis Trial in Dijon (drug, other, biological, procedure)

    Not yet recruiting
    • Giant Cell Arteritis
    • Tocilizumab treatment
    • +3 more
    • Dijon, France
      Chu Dijon Bourgogne
    Sep 7, 2023

    Healthy Volunteers Trial in France (COVID-19 Vaccine Janssen (Ad26.COV2-S))

    Recruiting
    • Healthy Volunteers
    • COVID-19 Vaccine Janssen (Ad26.COV2-S)
    • Dijon, France
    • +9 more
    Apr 21, 2022

    Covid19 Trial in Lyon, Saint-Étienne (COVID-19 vaccine Pfizer (2 doses), COVID-19 vaccine Pfizer (1 dose), COVID-19 mRNA Vaccine

    Recruiting
    • Covid19
    • COVID-19 vaccine Pfizer (2 doses)
    • +3 more
    • Lyon, France
    • +2 more
    Nov 17, 2021

    Chronic Lymphocytic Leukemia Trial in Tuebingen (Multipeptide Vaccine+ XS15)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Multipeptide Vaccine+ XS15
    • Tuebingen, BW, Germany
    • +1 more
    Sep 7, 2021

    Multiple Sclerosis Trial in Edegem (tolerogenic dendritic cells (tolDC))

    Active, not recruiting
    • Multiple Sclerosis
    • tolerogenic dendritic cells (tolDC)
    • Edegem, Belgium
      Antwerp University Hospital
    May 10, 2021

    Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +2 more
    • Blood sample collection
    • +4 more
    • Besançon, France
    • +4 more
    Nov 17, 2022

    Radiotherapy, Immunology Trial in Ghent (Cyclophosphamide, Stereotactic body radiotherapy)

    Withdrawn
    • Radiotherapy
    • Immunology
    • Ghent, Belgium
      University Hospital - Radiotherapy Department
    Jul 7, 2021

    NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor Trial in Boulogne

    Recruiting
    • NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor
    • assessment of the predictive value of ctDNA level of the prominent mutant allele variation between baseline and week 6, on response to treatment according to RECIST 1.1 criteria.
    • Boulogne Billancourt, France
    • +2 more
    Jul 12, 2021

    Neuroblastoma Trial in France (Immunological analyses)

    Unknown status
    • Neuroblastoma
    • Immunological analyses
    • Clermont Ferrand, France
    • +3 more
    Aug 22, 2018